) The CORE B Protein Expression Facility will provide investigators a common source of highly purified proteins and the technical knowledge for use of these proteins to meet the experimental objectives of this Program Project. The CORE will consolidate the efforts of six laboratories into one facility, eliminating unnecessary duplication of technical expertise and decreasing expresses for technical staff, while providing quality control for critical reagents. The CORE will provide active recombinant caspase, caspase inhibitory proteins (crmA, p35, IAPs), functional fragments of TNF family receptors, and functional fragments of TRAF-family proteins using bacterial and baculovirus expression systems. A formalized procedure for establishing priority reagent requests among the investigators are described. The CORE B will be located both at the Burnham Institute with bacterial expression under the direction of Dr. Welsh and at the La Jolla Institute for Allergy & Immunology with baculoviral expression under the direction of Dr. Ware.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA069381-07
Application #
6595006
Study Section
Project Start
2002-05-28
Project End
2003-04-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
7
Fiscal Year
2002
Total Cost
$168,360
Indirect Cost
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
009214214
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Xu, X-P; Zhai, D; Kim, E et al. (2013) Three-dimensional structure of Bax-mediated pores in membrane bilayers. Cell Death Dis 4:e683
Chipuk, Jerry E; McStay, Gavin P; Bharti, Archana et al. (2012) Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell 148:988-1000
Fujikura, D; Ito, M; Chiba, S et al. (2012) CLIPR-59 regulates TNF-?-induced apoptosis by controlling ubiquitination of RIP1. Cell Death Dis 3:e264
Garrison, Jason B; Correa, Ricardo G; Gerlic, Motti et al. (2011) ARTS and Siah collaborate in a pathway for XIAP degradation. Mol Cell 41:107-16
Lu, Jennifer V; Weist, Brian M; van Raam, Bram J et al. (2011) Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. Proc Natl Acad Sci U S A 108:15312-7
Ponder, Elizabeth L; Albrow, Victoria E; Leader, Brittany A et al. (2011) Functional characterization of a SUMO deconjugating protease of Plasmodium falciparum using newly identified small molecule inhibitors. Chem Biol 18:711-21
Timmer, John C; Salvesen, Guy S (2011) N-terminomics: a high-content screen for protease substrates and their cleavage sites. Methods Mol Biol 753:243-55
Oberst, Andrew; Dillon, Christopher P; Weinlich, Ricardo et al. (2011) Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471:363-7
Leverrier, S; Salvesen, G S; Walsh, C M (2011) Enzymatically active single chain caspase-8 maintains T-cell survival during clonal expansion. Cell Death Differ 18:90-8
Krajewska, Maryla; You, Zerong; Rong, Juan et al. (2011) Neuronal deletion of caspase 8 protects against brain injury in mouse models of controlled cortical impact and kainic acid-induced excitotoxicity. PLoS One 6:e24341

Showing the most recent 10 out of 192 publications